{"id":"initiation-of-cftr-modulator","safety":{"commonSideEffects":[{"rate":null,"effect":"Transaminase elevation"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL4303269","moleculeType":"Small molecule","molecularWeight":"389.86"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CFTR modulators work by either correcting the trafficking and localization of defective CFTR protein to the cell surface (correctors) or enhancing the channel-opening activity of CFTR at the membrane (potentiators). This restores the ability of epithelial cells to properly regulate salt and water balance, reducing the thick mucus secretions characteristic of cystic fibrosis.","oneSentence":"CFTR modulators restore function to the cystic fibrosis transmembrane conductance regulator (CFTR) protein, improving chloride ion transport across cell membranes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:48:59.173Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cystic fibrosis (specific mutations dependent on modulator type)"}]},"trialDetails":[{"nctId":"NCT04467957","phase":"PHASE4","title":"Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-11-15","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT04259970","phase":"PHASE4","title":"Hyperpolarized Imaging for New Treatments","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-01-13","conditions":"Cystic Fibrosis","enrollment":64},{"nctId":"NCT04206436","phase":"","title":"CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Indiana University","startDate":"2019-12-18","conditions":"Cystic Fibrosis, Bone Loss, Muscle Loss","enrollment":63},{"nctId":"NCT05663255","phase":"","title":"Effectiveness of CFTR Modulators According to Co-therapy","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2023-03-01","conditions":"Cystic Fibrosis","enrollment":1990}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":233,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["129Xe"],"phase":"marketed","status":"active","brandName":"Initiation of CFTR Modulator","genericName":"Initiation of CFTR Modulator","companyName":"Children's Hospital Medical Center, Cincinnati","companyId":"children-s-hospital-medical-center-cincinnati","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CFTR modulators restore function to the cystic fibrosis transmembrane conductance regulator (CFTR) protein, improving chloride ion transport across cell membranes. Used for Cystic fibrosis (specific mutations dependent on modulator type).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}